Exhibit C

Joint Filing Statement

I, the undersigned, hereby express my agreement that the attached Schedule 13D (and any amendments thereto) relating to the beneficial ownership by the undersigned of the equity securities of Repare Therapeutics Inc. is filed on behalf of each of the undersigned.

Date: July 6, 2020

MPM BIOVENTURES 2014, L.P.
By:	MPM BioVentures 2014 GP LLC,
	its General Partner
By:	MPM BioVentures 2014 LLC,
	Its Managing Member

By:	/s/ Luke Evnin
Name:	Luke Evnin
Title:	Managing Director

MPM BIOVENTURES 2014 (B), L.P.
By:	MPM BioVentures 2014 GP LLC,
	its General Partner
By:	MPM BioVentures 2014 LLC,
	Its Managing Member

By:	/s/ Luke Evnin
Name:	Luke Evnin
Title:	Managing Director
MPM ASSET MANAGEMENT INVESTORS BV 2014 LLC
By:	/s/ Howard Rubin
Name:	Howard Rubin
Title:	Director

MPM BIOVENTURES 2014 GP, LLC
By:	MPM BioVentures 2014 LLC,
	Its Managing Member

By:	/s/ Luke Evnin
Name:	Luke Evnin
Title:	Managing Director
MPM BIOVENTURES 2014 LLC
By:	/s/ Luke Evnin
Name:	Luke Evnin
Title:	Managing Director

UBS ONCOLOGY IMPACT FUND , L.P.
By:	Oncology Impact Fund (Cayman) Management L.P.,
	its General Partner
By:	MPM Oncology Impact Management LP,
	Its General Partner
By:	MPM Oncology Impact Management GP LLC
	Its General Partner

By:	/s/ Ansbert Gadicke
Name:	Ansbert Gadicke
Title:	Managing Director

ONCOLOGY IMPACT FUND (CAYMAN) MANAGEMENT L.P.
By:	MPM Oncology Impact Management LP,
	Its General Partner
By:	MPM Oncology Impact Management GP LLC
	Its General Partner

By:	/s/ Ansbert Gadicke
Name:	Ansbert Gadicke
Title:	Managing Director

MPM ONCOLOGY IMPACT MANAGEMENT LP
By:	MPM Oncology Impact Management GP LLC
	Its General Partner

By:	/s/ Ansbert Gadicke
Name:	Ansbert Gadicke
Title:	Managing Director

2

MPM ONCOLOGY IMPACT MANAGEMENT GP LLC
By:	/s/ Ansbert Gadicke
Name:	Ansbert Gadicke
Title:	Managing Director
By:	/s/ Todd Foley
Name:	Todd Foley
By:	/s/ Luke Evnin
Name:	Luke Evnin
By:	/s/ Ansbert Gadicke
Name:	Ansbert Gadicke

3